Eli Lilly (LLY)
(Delayed Data from NYSE)
$764.71 USD
+16.52 (2.21%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $764.00 -0.71 (-0.09%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
For Eli Lilly and Company, the company has a dividend yield of 0.80% compared to the Large Cap Pharmaceuticals industry's yield of 2.13%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
LLY 764.71 +16.52(2.21%)
Will LLY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LLY
Why the Market Dipped But Eli Lilly (LLY) Gained Today
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD?
Will Rybelsus' Updated EU Label Propel Fresh Growth Potential for NVO?
Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?
Other News for LLY
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
Eli Lilly (LLY) Faces Investor Concerns Over Recent Trial Data
Eli Lilly's (LLY) Peresolimab Faces Efficacy Challenges in Rheumatoid Arthritis Treatment
Eli Lilly (LLY) Commits $5B to New Manufacturing Facility in Virginia
AnaptysBio falls after data abstract on Lilly’s peresolimab